TITLE

A new class of antimycobacterial drugs: the diarylquinolines

AUTHOR(S)
Samson, I.
PUB. DATE
June 2005
SOURCE
Thorax;Jun2005, Vol. 60 Issue 6, p492
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The article presents information about R207910, a diarylquinoline drug. The drug acts as an inhibitor of mycobacterial ATP synthase, a different mechanism of action from any other anti-TB drug. It is specific in activity to mycobacteria, including the opportunistic species, with in vivo bactericidal activity against M tuberculosis in a murine model. Animal and human pharmacokinetic and pharmacodynamic studies showed that R207910 has a long plasma half life, good tissue penetration, and potential for a dose regimen of less than five doses per week, making it ideal for DOT.
ACCESSION #
17359839

 

Related Articles

  • PrÄ…tki niegruźlicze: M. marinum, M. ulcerans, M. xenopi - krótka charakterystyka drobnoustrojów i zmian klinicznych przez nie wywoÅ‚ywanych. Fol, Marek; Olek, Joanna; Kowalewicz-Kulbat, Magdalena; Druszczyńska, Magdalena; Rudnicka, Wiesława // Advances in Hygiene & Experimental Medicine / Postepy Higieny i ;2011, Vol. 65, p574 

    Mycobacterium is a variable group of acid-fast bacillus which contains pathogenic bacteria causing tuberculosis (MTC - Mycobacterium tuberculosis complex) and leprosy (M. leprae) as well as numerous nontuberculous mycobacteria (NTM) causing diseases mostly in people with immunodeficiency,...

  • Serum Concentrations of Antimycobacterial Drugs in Patients with Pulmonary Tuberculosis in Botswana. Tappero, Jordan W.; Bradford, Williamson Z.; Agerton, Tracy B.; Hopewell, Philip; Reingold, Arthur L.; Lockman, Shahin; Oyewo, Aderonke; Talbot, Elizabeth A.; Kenyon, Thomas A.; Moeti, Themba L; Moffat, Howard J.; Peloquin, Charles A. // Clinical Infectious Diseases;8/15/2005, Vol. 41 Issue 4, p461 

    Background. We conducted a pharmacokinetic study of antimycobacterial drugs involving a cohort of patients with pulmonary tuberculosis (TB) in Gaborone, Botswana, to assess the prevalence of and risk factors for low drug concentrations in serum. Methods. Adults participated if they had a history...

  • New Drug Combo Could Speed TB Treatment: U.S. Study.  // Clinical Infectious Diseases;11/15/2007, Vol. 45 Issue 10, piii 

    The article cites a study from the U.S. that reported on the ability of a drug combination to accelerate treatment of tuberculosis (TB). Researchers found that adding a new antibiotic to the standard mix of drugs used to treat TB could shorten the grueling six-month regimen. By substituting the...

  • In Vitro Efficacy of Fusidic Acid on Drug Resistant Strains of Mycobacterium Tuberculosis. Öztaş, Selahattin; Kurutepe, Melahat; Adıgüzel, Nalan; Acartürk, Eylem; Saraç, Sema; Maraşlı, Dida; Tümer, Özlen; Hazar, Armağan // Turk Toraks Dergisi / Turkish Thoracic Journal;Sep2008, Vol. 9 Issue 3, p109 

    Introduction: We aimed to investigate the in vitro efficacy of fusidic acid (FA) on tuberculosis strains resistant to antituberculous drugs . Material and Method: In our single center, prospective, randomized controlled study, we researched the efficacy of sodium fucidate on tuberculosis bacilli...

  • Coexistence of Tuberculosis Verrucosa Cutis with Scrofuloderma. Gönül, Müzeyyen; Gül, Ülker; Kiliç, Arzu; Soylu, Seçil; Demiriz, Murat; Kubar, Ayhan // Turkish Journal of Medical Sciences;2008, Vol. 38 Issue 5, p495 

    Although cutaneous tuberculosis is rarely seen in developed countries, it is still commonly seen in developing countries. Tuberculosis verrucosa cutis (TVC) is a form of cutaneous tuberculosis that is caused by direct inoculation of Mycobacterium tuberculosis into the skin through open wounds or...

  • Pulmonary Infection and Colonization with Nontuberculous Mycobacteria, Taiwan, 2000-2012. Jung-Yien Chien; Chih-Cheng Lai; Wang-Huei Sheng; Chong-Jen Yu; Po-Ren Hsueh // Emerging Infectious Diseases;Aug2014, Vol. 20 Issue 8, p1382 

    We analyzed samples from 13,652 patients who had respiratory cultures positive for mycobacteria in Taiwan during 2000-2012 and found that 56.9% were positive for nontuberculous mycobacteria (NTM). Whereas annual prevalence of tuberculosis decreased during the study period, prevalence of NTM...

  • Tuberculosis: The genetics of vulnerability. Jabado, Nada; Gros, Philippe // Nature;4/7/2005, Vol. 434 Issue 7034, p709 

    Presents a study which provided insight into the novel aspect of tuberculosis (TB) pathogenesis and the possible revelation of a new molecular targets for drug treatments if validated in humans. Factors contributed in considering TB as an innate and major global health problem; Relationship of...

  • The Impact of Nontuberculous Mycobacteria on Management of Presumed Pulmonary Tuberculosis. van Crevel, R.; de Lange, W. C. M.; Vanderpuye, N. A.; van Soolingen, D.; Hoogkamp-Korstanje, J. A. A.; van Deuren, M.; Kullberg, B. J.; van Herwaarden, C.; van der Meer, J. W. M. // Infection;Apr2001, Vol. 29 Issue 2, p59 

    Background: The presence of nontuberculous mycobacteria (NTM) in sputum or bronchial washings may cause diagnostic problems which affect clinical, management. Patients and Methods: In a retrospective analysis of 135 patients in a Dutch tuberculosis center, patients with NTM isolates were...

  • Pulmonary Tuberculosis due to Mycobacterium bovis subsp. caprae in Captive Siberian Tiger. Lantos, Akos; Niemann, Stefan; Mezosi, Laszlo; Sos, Endre; Erdelyi, Karoly; David, Sandor; Parsons, Linda M.; Kubica, Tanja; Rusch-Gerdes, Sabine; Somoskovi, Akos // Emerging Infectious Diseases;Nov2003, Vol. 9 Issue 11, p1462 

    We report the first case of pulmonary tuberculosis caused by Mycobacterium bovis subsp, caprae in a captive Siberian tiger, an endangered feline. The pathogen was isolated from a tracheal aspirate obtained by bronchoscopy. This procedure provided a reliable in vivo diagnostic method in...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics